Treatment options for adult intermediate-risk AML patients in CR1: Allo-HSCT or chemotherapy?
oleh: Luxiang Wang, Chunli Zhang, Shuang Fan, Xiaodong Mo, Xiaoxia Hu
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2023-07-01 |
Deskripsi
No description available for this item.